fda approves semaglutide for cardiovascular risk reduction Wegovy, the weight-loss medication, gets approval use as heart disease prevention drug FDA approves weight-loss drug Wegovy

Many people report feeling more energetic within a few days, while others notice gradual improvement over one to two weeks

These primary antioxidants exist within our cells and are essential for cellular defence, detoxification and function

Earlier this month, new research published in eClinicalMedicine showed that semaglutide was associated with significantly lower risk of dementia and nicotine misuse versus other diabetes therapies, such as sitagliptin and glipizide

In comparison to FEHB and PSHB, CalPERS, which purchases health insurance for California state government employees, announced an average premium increase of 10.79% for 2025